Diagnostic accuracy of diffusion weighted magnetic resonance imaging in differentiating benign and malignant meningioma taking histopathology as gold standard.
DOI:
https://doi.org/10.29309/TPMJ/2026.33.01.10085Keywords:
Diffusion-Weighted Imaging, DWI-MRI, Histopathology, Meningioma, Magnetic Resonance ImagingAbstract
Objective: To evaluate the ability of diffusion-weighted MR Imaging to distinguish malignant meningiomas from benign, taking histopathology as the gold standard. Study Design: Cross-Sectional Validation Study. Setting: Department of Radiology, Aziz Fatimah Hospital and Allied Hospital, Faisalabad. Period: October 2024 to April 2025. Methods: A total of 225 patients aged between 20 to 60 years with suspected meningiomas were enrolled. DWI-MRI was performed using a 1.5 Tesla scanner (b-values 0, 500, and 1000 s/mm²). Findings were interpreted by a consultant radiologist and compared with histopathology. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were calculated using SPSS version 20.0; a p-value < 0.05 was considered significant. Results: DWI-MRI showed a high diagnostic accuracy (86.67%) in distinguishing malignant from benign meningiomas, with sensitivity 88.52%, specificity 84.47%, PPV 87.10% and NPV 86.14% (p = 0.0001). Conclusion: DWI-MRI is a reliable, non-invasive imaging modality with high diagnostic accuracy for differentiating benign and malignant meningiomas and can significantly aid in preoperative assessment and treatment planning.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 The Professional Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.